BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Art Pappas is participating in a health reform panel discussion for the Capitolbeat Annual Conference in Indianapolis, IN
News | 08. 21. 2009
